Cellular accumulation of dietary anticarcinogenic isothiocyanates is followed by transporter-mediated export as dithiocarbamates

Cancer Letters

Volumn 204, Issue 1, 2004, Pages 23-31

  Callaway, Eileen C ^a   Zhang, Yuesheng ^a,b   Chew, Wade ^a   Chow, H H Sherry ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Allyl isothiocyanate; Benzyl isothiocyanate; Isothiocyanate; Isothiocyanate transport; Multidrug resistance associated protein 1; P glycoprotein 1; Phenethyl isothiocyanate

Indexed keywords

ALLYL ISOTHIOCYANATE; ANTINEOPLASTIC AGENT; BENZYL ISOTHIOCYANATE; CYCLOSPORIN A; CYSTEINYLGLYCINE; DITHIOCARBAMIC ACID; GLUTATHIONE; GLYCOPROTEIN P; ISOTHIOCYANIC ACID DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN 1; PHENETHYL ISOTHIOCYANATE; SULFORAPHANE; VERLUKAST;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL STRAIN HL 60; CELL TRANSPORT; CONJUGATION; CONTROLLED STUDY; DIET; DRUG ACCUMULATION; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL;

EID: 1642523398     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.09.021     Document Type: Article

References (26)

1. Zhang Y., Talalay P. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res. 54:1994;1976s-1981s.
2. Hecht S.S. Chemoprevention by isothiocyanates. J. Nutr. 22:1995;195-209.
3. Conaway C.C., Yang Y.M., Chung F.L. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr. Drug Metab. 3:2002;233-255.
4. London S.J., Yuan J.M., Chung F.L., Gao Y.T., Coetzee G.A., Ross R.K., Yu M.C. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet. 356:2000;724-729.
5. Spitz M.R., Duphorne C.M., Detry M.A., Pillow P.C., Amos C.I., Lei L., et al. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomark. Prev. 9:2000;1017-1020.
6. Lin H.J., Zhou H., Dai A., Huang H.F., Lin J.H., Frankl H.D., et al. Glutathione transferase GSTT1, broccoli, and prevalence of colorectal adenomas. Pharmacogenetics. 12:2002;175-179.
7. Thornalley P. Isothiocyanates: mechanism of cancer chemopreventive action. Anti-Cancer Drugs. 13:2002;331-338.
8. Zhang Y., Talalay P. Mechanisms of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res. 58:1998;4632-4639.
9. Zhang Y. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis. 21:2000;1175-1182.
10. Zhang Y., Callaway E.C. High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem. J. 364:2002;301-307.
11. Zhang Y. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis. 22:2001;425-431.
12. Ye L., Zhang Y. Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes. Carcinogenesis. 22:2001;1987-1992.
13. Chiao J.W., Chung F.L., Kancherla R., Ahmed T., Mittelman A., Conaway C.C. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol. 20:2002;631-636.
14. Yang Y.M., Conaway C.C., Chiao J.W., Wang C.X., Amin S., Whysner J., et al. Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis. Cancer Res. 62:2002;2-7.
15. Jiao D., Smith T.J., Yang C.S., Pittman B., Desai D., Amin S., Chung F.L. Chemopreventive activity of thiol conjugates of isothiocyanates for lung tumorigenesis. Carcinogenesis. 18:1997;2143-2147.
16. Brusewitz G., Cameron B.D., Chasseaud L.F., Gorler K., Hawkins D.R., Koch H., Wennicke W.H. The metabolism of benzyl isothiocyanate and its cysteine conjugate. Biochem. J. 162:1977;99-107.
17. Mennicke W.H., Gorler K., Krumbiegel G. Metabolism of some naturally occurring isothiocyanates in the rat. Xenobiotica. 13:1983;203-207.
18. Mennicke W.H., Gorler K., Krumbiegel G., Lorenz D., Rittmann N. Studies on the metabolism and excretion of benzyl isothiocyanate in man. Xenobiotica. 18:1988;441-447.
19. Zhang Y., Wade K.L., Prestera T., Talalay P. Quantitative determination of isothiocyanates, dithiocarbamates, carbon disulfide and related thiocarbonyl compounds by cyclocondensation assay with 1,2-benzenedithiol. Anal. Biochem. 239:1996;160-167.
20. Krishnamachary N., Center M.S. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53:1993;3658-3661.
21. Lautier D., Canitrot Y., Deeley R.G., Cole S.P.C. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem. Pharmacol. 52:1996;967-977.
22. Kool M., Van Der Linden M., De Haas M., Scheffer G.L., De Vree J.M.L., Smith A.J., et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA. 96:1999;6914-6919.
23. Zhu B.T. A novel hypothesis for the mechanism of action of P-glycoprotein as a multidrug transporter. Mol. Carcinog. 25:1999;1-13.
24. Vernhet L., Courtois A., Allain N., Payen L., Anger J.-P., Guillouzo A., Fardel O. Overexpression of the multidrug resistance-associated protein (MRP-1) in human heavy metal-selected tumor cells. Fed. Eur. Biochem. Sci. Lett. 443:1999;321-325.
25. Sturm A., Ziemann C., Hirsch-Ernst K.I., Segner H. Expression and functional activity of P-glycoprotein in cultured hepatocytes from Oncorhynchus mykiss. Am. J. Physiol. Regul. Integrat. Comp. Physiol. 281:2001;R1119-R1126.
26. Payen L., Courtois A., Campion J.-P., Guillouzo A., Fardel O. Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes. Biochem. Pharmacol. 60:2000;1967-1975.